Advair HFA 45/21mcg Oralinh 120s

Manufacturer GLAXO SMITH KLINE Active Ingredient Fluticasone and Salmeterol Inhaler(floo TIK a sone & sal ME te role) Pronunciation AD-vair H-F-A (floo TIK a sone & sal ME te role)
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Bronchodilator/Corticosteroid Combination
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA) Combination
🀰
Pregnancy Category
Not available
βœ…
FDA Approved
Aug 2006
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Advair HFA is an inhaler that contains two medicines: one to reduce swelling and inflammation in your lungs (fluticasone) and another to help open up your airways for easier breathing (salmeterol). It's used twice a day, every day, to help control asthma or COPD symptoms and prevent flare-ups. It is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. This medication is for inhalation only.

Key Instructions:

Continue using this medication as directed by your doctor or healthcare provider, even if you feel well.
Take this medication at the same time every day to establish a routine.
After each use, rinse your mouth with water and spit it out - do not swallow the rinse water.
If you are using multiple inhaled medications, consult your doctor about which one to use first.
Before using the inhaler, shake it well.
Prior to the first use, prime the inhaler by spraying 4 test sprays into the air, away from your face. If the inhaler has not been used for more than 4 weeks or has been dropped, prime it again with 2 sprays into the air, away from your face, shaking well before each test spray.
Replace the cap on the inhaler after each use.

Important Safety Precautions:

This medication is flammable, so avoid using it near an open flame or while smoking.
Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, discard it when the counter reaches "0".

Storage and Disposal:

Store this medication at room temperature in a dry place, avoiding bathrooms.
Keep the inhaler stored with the mouthpiece facing down.

Missed Dose:

If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Use Advair HFA regularly, twice a day, every day, even if you feel well. Do not stop using it without talking to your doctor.
  • This is not a rescue inhaler. Always carry your fast-acting rescue inhaler (e.g., albuterol) for sudden breathing problems.
  • Rinse your mouth with water and spit it out after each use of Advair HFA to help prevent a fungal infection (thrush) in your mouth and throat.
  • Learn and practice proper inhaler technique as demonstrated by your healthcare provider. Incorrect technique can reduce effectiveness.
  • Keep track of your symptoms and how often you use your rescue inhaler. Report any worsening symptoms to your doctor.
  • Avoid your known asthma or COPD triggers (e.g., smoke, allergens, pollution).
  • Do not exceed the prescribed dose. Using too much can increase side effects.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 2 inhalations twice daily (morning and evening), approximately 12 hours apart
Dose Range: 45 - 21 mg

Condition-Specific Dosing:

asthma: 2 inhalations of Advair HFA 45/21 mcg twice daily
COPD: 2 inhalations of Advair HFA 45/21 mcg twice daily
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength (Advair HFA is approved for asthma in patients 12 years and older, but specific dosing for younger children varies by strength and product type)
Adolescent: For asthma in patients 12 years and older: 2 inhalations of Advair HFA 45/21 mcg twice daily
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; monitor for systemic effects if severe impairment

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Use with caution; monitor for increased systemic corticosteroid effects
Severe: Use with caution; monitor for increased systemic corticosteroid effects

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing bronchial hyperresponsiveness. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It acts locally in the lung to relax bronchial smooth muscle by stimulating beta2-receptors, leading to bronchodilation. The combination provides both anti-inflammatory and bronchodilator effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (<30% for inhaled dose due to extensive first-pass metabolism and incomplete oral absorption). Salmeterol: Low systemic bioavailability (negligible after inhaled dose due to extensive first-pass metabolism).
Tmax: Fluticasone: Approximately 0.5-1 hour. Salmeterol: Approximately 5-10 minutes.
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: Fluticasone: Approximately 318 L. Salmeterol: Approximately 1500 L.
ProteinBinding: Fluticasone: Approximately 91%. Salmeterol: Approximately 96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: Approximately 8 hours (terminal half-life). Salmeterol: Approximately 5.5 hours (terminal half-life).
Clearance: Fluticasone: High systemic clearance (approximately 1150 mL/min). Salmeterol: High systemic clearance (approximately 1200 mL/min).
ExcretionRoute: Fluticasone: Primarily fecal (via biliary excretion), with less than 5% excreted renally. Salmeterol: Primarily fecal (approximately 60%), with approximately 25% excreted renally.
Unchanged: Fluticasone: Negligible amount excreted unchanged. Salmeterol: Negligible amount excreted unchanged.
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: Within 30-45 minutes (significant bronchodilation). Fluticasone: Anti-inflammatory effects may take several days to weeks to become maximal.
PeakEffect: Salmeterol: Approximately 2-4 hours. Fluticasone: Varies, full therapeutic effect may take 1-2 weeks.
DurationOfAction: Salmeterol: Approximately 12 hours. Fluticasone: Sustained anti-inflammatory effect with twice-daily dosing.

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma (SMART study) showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of LABAs. The concomitant use of inhaled corticosteroids (ICS) and LABAs has been shown to decrease the risk of asthma-related hospitalization, but not asthma-related death. Advair HFA is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Important Warning: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold

This list is not exhaustive. If you have questions about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for your rescue inhaler
  • Chest pain or fast/pounding heartbeat (palpitations)
  • Tremor or nervousness
  • Signs of an allergic reaction (e.g., rash, hives, swelling of face/mouth/tongue, severe dizziness, trouble breathing)
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • White patches in your mouth or throat (oral thrush)
  • Vision changes (e.g., blurred vision, eye pain)
  • Unusual tiredness, weakness, nausea, vomiting, or dizziness (signs of adrenal suppression)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist to determine if the medication is similar.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this medication.

To ensure your safety, it is crucial to discuss all of your medications (prescription or OTC, natural products, vitamins) and health conditions with your doctor and pharmacist. This will help determine if it is safe to take this medication with your existing medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Information About Your Medication

It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. You may not feel the full effects of this medication for approximately 1 week.

If you have diabetes (high blood sugar), consult with your doctor, as this medication may cause an increase in blood sugar levels. Monitor your breathing problems closely, and contact your doctor immediately if they worsen, if your rescue inhaler becomes less effective, or if you need to use it more frequently.

Dosage and Administration

Do not exceed the recommended dose or frequency of this medication, as overdoses have been fatal. Consult with your doctor if you have any questions or concerns.

Special Considerations

When transitioning from an oral steroid to a different form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of signs such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these symptoms.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card with you to alert healthcare providers of this potential need.

Long-term Use and Potential Side Effects

Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Consult with your doctor and schedule regular eye exams as recommended.

Long-term use may also lead to osteoporosis (weak bones). Discuss your individual risk factors with your doctor and undergo bone density tests as advised.

Infection Risk and Prevention

You may be more susceptible to infections while taking this medication. To minimize your risk, practice good hygiene by washing your hands frequently, and avoid close contact with individuals who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult with your doctor promptly.

Special Populations

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary, so consult with your doctor.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks of this medication with your doctor.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia, arrhythmias, tremor, headache, nausea, muscle cramps, hypokalemia, hyperglycemia.
  • Fluticasone overdose (acute): Generally well-tolerated, but chronic overdose may lead to signs of hypercorticism (e.g., Cushingoid features, adrenal suppression).

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For advice, call a poison control center at 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function and serum potassium levels.

Drug Interactions

🚫

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, telithromycin, nefazodone) due to increased systemic exposure of fluticasone and salmeterol, leading to increased risk of cardiovascular and systemic corticosteroid adverse effects.
πŸ”΄

Major Interactions

  • Beta-blockers (especially non-selective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm in patients with asthma. Use with caution and only if no suitable alternative.
  • Other long-acting beta2-agonists (LABAs): Concomitant use is not recommended as it may lead to overdose of LABA.
  • Diuretics (loop or thiazide): May potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension). Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
🟑

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil): May increase systemic exposure of fluticasone and salmeterol, requiring caution and monitoring.
  • Other sympathomimetics: Concomitant use may potentiate adverse cardiovascular effects.
🟒

Minor Interactions

  • Not specifically listed as minor interactions; most interactions are significant due to the nature of the active ingredients.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Asthma/COPD Control Assessment

Rationale: To evaluate baseline symptom frequency, severity, and impact on daily life.

Timing: Prior to initiation of therapy.

Adrenal Function (if switching from oral corticosteroids)

Rationale: To assess for potential adrenal suppression.

Timing: Prior to or during transition from systemic corticosteroids.

πŸ“Š

Routine Monitoring

Asthma/COPD Symptom Control

Frequency: Regularly (e.g., at each follow-up visit, patient self-monitoring daily)

Target: Minimal symptoms, infrequent rescue inhaler use, no nocturnal awakenings.

Action Threshold: Worsening symptoms, increased rescue inhaler use, nocturnal awakenings, decreased peak flow readings.

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 3-12 months for stable patients, more frequently if unstable)

Target: Improvement or maintenance of lung function.

Action Threshold: Significant decline in FEV1.

Growth in Pediatric Patients

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity.

Action Threshold: Growth retardation.

Signs of Oral Candidiasis (Thrush)

Frequency: At each visit, patient self-monitoring daily

Target: Absence of white patches in mouth/throat.

Action Threshold: Presence of white patches, soreness.

Signs of Systemic Corticosteroid Effects (e.g., Cushingoid features, adrenal suppression)

Frequency: Periodically, especially with higher doses or prolonged use

Target: Absence of signs/symptoms.

Action Threshold: Development of signs/symptoms.

Ocular Examination (for cataracts/glaucoma)

Frequency: Annually for patients at risk or on long-term therapy

Target: Normal intraocular pressure, absence of cataracts.

Action Threshold: Increased intraocular pressure, vision changes.

Serum Potassium and Glucose (if clinically indicated or with interacting drugs)

Frequency: As needed, especially with high doses or concomitant diuretics

Target: Normal ranges.

Action Threshold: Hypokalemia, hyperglycemia.

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased frequency of rescue inhaler use
  • Decreased peak expiratory flow (PEF) readings
  • Nocturnal awakenings due to respiratory symptoms
  • Signs of oral candidiasis (white patches in mouth/throat)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain)
  • Paradoxical bronchospasm (immediate worsening of breathing after inhalation)
  • Cardiovascular symptoms (e.g., palpitations, chest pain, rapid heart rate, tremor)
  • Signs of infection (e.g., fever, increased sputum production, change in sputum color)

Special Patient Groups

🀰

Pregnancy

Advair HFA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Uncontrolled asthma in pregnancy poses a greater risk to both mother and fetus than the potential risks of medication. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though systemic exposure is low with inhaled use.
Second Trimester: Continued need for asthma control; monitor for fetal growth.
Third Trimester: Continued need for asthma control; monitor for potential effects on labor and delivery.
🀱

Lactation

It is not known whether fluticasone propionate or salmeterol xinafoate are excreted in human breast milk. However, other corticosteroids and beta2-agonists are excreted. Caution should be exercised when Advair HFA is administered to a nursing mother. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Advair HFA and any potential adverse effects on the breastfed infant from Advair HFA or from the underlying maternal condition.

Infant Risk: Low systemic exposure in the mother suggests low levels in breast milk, but potential for infant exposure exists. Monitor for signs of systemic corticosteroid effects or beta-agonist effects in the infant.
πŸ‘Ά

Pediatric Use

Advair HFA is approved for asthma in patients 12 years of age and older. Safety and effectiveness in children younger than 12 years have not been established. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth rate.

πŸ‘΄

Geriatric Use

No dosage adjustment is required based on age. However, elderly patients may be more susceptible to the cardiovascular effects of beta2-agonists and may have age-related decreases in hepatic or renal function, which could affect drug clearance. Monitor for comorbidities and potential drug interactions.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Advair HFA is a maintenance medication and should not be used for acute bronchospasm. Patients should always have a rescue inhaler available.
  • Proper inhaler technique is critical for drug delivery and efficacy. Patients should be instructed and regularly re-evaluated on their technique.
  • Rinsing the mouth with water and spitting after each dose helps prevent oral candidiasis (thrush).
  • Patients should be advised not to stop Advair HFA abruptly, especially if they have been on high doses or for prolonged periods, due to the risk of adrenal insufficiency.
  • Monitor for signs of pneumonia in COPD patients, as ICS use may increase this risk.
  • Patients should be aware of the Black Box Warning regarding LABAs and asthma-related death, but also understand that the combination with an ICS mitigates this risk for asthma patients.
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide)
  • Long-Acting Muscarinic Antagonist (LAMA) monotherapy (e.g., tiotropium, umeclidinium) for COPD
  • Short-Acting Beta2-Agonists (SABAs) for rescue (e.g., albuterol)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations or refractory disease)
πŸ’°

Cost & Coverage

Average Cost: $300 - $450 per 120 actuations inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Preferred or Non-Preferred Brand)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.